{rfName}
La

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Hurtado-Marcos CAuthorIzquierdo FAuthorFenoy SAuthorSáez YAuthorMagnet AAuthorDel Aguila CAuthor

Share

November 17, 2022
Publications
>
Article

Latent Microsporidia Infection Prevalence as a Risk Factor in Colon Cancer Patients

Publicated to:Cancers. 14 (21): 5342- - 2022-11-01 14(21), DOI: 10.3390/cancers14215342

Authors: Redondo, Fernando; Hurtado-Marcos, Carolina; Izquierdo, Fernando; Cuellar, Carmen; Fenoy, Soledad; Saez, Yanira; Magnet, Angela; Galindo-Regal, Lorena; Uribe, Natalia; Lopez-Baneres, Manuel; Isabel Jimenez, Ana; Llombart-Cussac, Antonio; Del Aguila, Carmen; Carlos Andreu-Ballester, Juan

Affiliations

Arnau de Vilanova Univ Hosp, Dept Gen & Digest Surg, Valencia 46015, Spain - Author
Arnau de Vilanova Univ Hosp, FISABIO Fdn, C San Clemente 12, Valencia 46015, Spain - Author
Arnau de Vilanova Univ Hosp, FISABIO Fdn, Lab Mol Biol, Valencia 46015, Spain - Author
Arnau de Vilanova Univ Hosp, FISABIO Fdn, Res Dept, Valencia 46015, Spain - Author
Arnau de Vilanova Univ Hosp, Pathol Dept, Valencia 46015, Spain - Author
Arnau de Vilanova Univ Hosp, Res Dept, C San Clemente 12, Valencia 46015, Spain - Author
Catholic Univ Valencia, Arnau de Vilanova Hosp, Med Oncol Dept, Valencia 46015, Spain - Author
Univ Complutense Madrid, Dept Microbiol & Parasitol, Madrid 28040, Spain - Author
Univ San Pablo CEU, CEU Univ, Fac Farm, Boadilla Del Monte 28660, Spain - Author
See more

Abstract

Keywords

antibodiescolon cancercryptosporidiumelisaencephalitozoon spenterocytozoon bieneusiidentificationifatparasitesColon cancerElisaEncephalitozoon sp.EncephalitozoonspEnterocytozoon bieneusiEnterocytozoon-bieneusiIfatMicrosporidia

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Cancers due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 4.41, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-04, the following number of citations:

  • WoS: 9
  • Scopus: 9
  • Europe PMC: 9

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 14.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 14 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 2.35.
  • The number of mentions on the social network X (formerly Twitter): 3 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Redondo F) .